Translational Medicine of Aging (TMA) is a scholarly journal dedicated to publishing research in the field of Medicine, and Published by KeAi Communications Co. and its abbreviation is Transl Med Aging.
The latest Impact Factor of the Translational Medicine of Aging for 2026-2027 is 2.38.
The Publication fees (APC) is 780 USD.
Translational Medicine of AgingΒ is a peer-reviewed international journal publishing original works and reviews in the area of the fundamental biology of aging as well as applications and intervention in aging and aging associated disorders. This is the first journal to focus specifically on the translational aspects of aging, integrating basic research and clinical/experimental medicine.
| Journal title | Translational Medicine of Aging (TMA) |
| Abbreviation | Transl Med Aging |
| Online ISSN | 2468-5011 |
| Publisher Name | KeAi Communications Co |
| Editor-in-chief | Prof. Zhongjun Zhou |
| Subject Category | Medicine |
| Access type | π’ Open Access |
| Status | π’ Active |
In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.
Below are the metrics and rankings for the journal Translational Medicine of Aging
| Impact Factor | 2.38 |
| SJR | 0.627 |
| SNIP | 0.444 |
| Ranking | 8158 |
| CiteScore | 5.5 |
| H-Index | 10 |
| Quartile | Q2 |
Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars
| Abstracting and Indexing |
If you would like to submit a manuscript or visit the journal's website, please click on the link below.
| Journal Submission | π Journal Website |
Add the app to your device for one-tap access.